ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,894.89
-0.28%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Interleukin Genetics, (ILI)

  7. Interleukin Genetics, (ILI) Noticias

ILI

Interleukin Genetics (ILI)

Interleukin Genetics,
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:ILI
FechaHoraFuenteTítuloSímboloCompañía
12/08/201015:07Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
05/08/201015:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
05/08/201007:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
05/08/201006:02Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
05/05/201005:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ILIInterleukin Genetics,
30/04/201018:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
30/04/201012:15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ILIInterleukin Genetics,
13/04/201016:04Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
25/03/201015:13Edgar (US Regulatory)Annual Report (10-K)AMEX:ILIInterleukin Genetics,
10/03/201016:11Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)AMEX:ILIInterleukin Genetics,
09/03/201008:46Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
05/03/201013:52Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:ILIInterleukin Genetics,
04/02/201006:00PR Newswire (US)Interleukin Genetics to Present at the 12th Annual BIO CEO ConferenceAMEX:ILI
19/01/201006:30PR Newswire (US)LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in EuropeAMEX:ILI
06/01/201009:44Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(2) (424B2)AMEX:ILIInterleukin Genetics,
06/01/201005:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:ILIInterleukin Genetics,
17/12/200906:30PR Newswire (US)Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone MiAMEX:ILI
07/12/200906:30PR Newswire (US)Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New YorkAMEX:ILI
02/12/200908:15PR Newswire (US)Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of OsteoarthritisAMEX:ILI
12/11/200915:20PR Newswire (US)Interleukin Genetics Reports Third Quarter 2009 Financial ResultsAMEX:ILI
05/11/200906:00PR Newswire (US)Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 ResultsAMEX:ILI
29/10/200906:00PR Newswire (US)Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic TestsAMEX:ILI
13/10/200906:00PR Newswire (US)Interleukin Genetics to Present Research Findings at Upcoming Medical MeetingsAMEX:ILI
23/09/200906:00PR Newswire (US)Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight LossAMEX:ILI
13/08/200915:20PR Newswire (US)Interleukin Genetics Reports Second Quarter 2009 Financial ResultsAMEX:ILI
06/08/200906:30PR Newswire (US)Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 ResultsAMEX:ILI
02/07/200906:00PR Newswire (US)Interleukin Genetics Announces Strategic Divestment of Alan James GroupAMEX:ILI
08/06/200908:00PR Newswire (US)Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to WellnessAMEX:ILI
05/06/200913:00PR Newswire (US)Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual MeetingAMEX:ILI
15/05/200908:00PR Newswire (US)Interleukin Genetics to Present at the 2009 BIO Business ForumAMEX:ILI
 Showing the most relevant articles for your search:AMEX:ILI

Su Consulta Reciente

LSE
HTRY
Hsbc Msci Trky
USOTC
PWEI
PacWest Equities (CE)
NYSE
TPGH.WS
TPG Pace
EU
XS1991342301
Domi 2019 1 BV Frn until...
EU
XS2558022591
ABN AMRO International b...
HITB
DRTETH
DomRaiderToken
USOTC
CHMCF
Chinaamc ETF Ser Unit (CE)
LSE
57TA
Bluestone C
EU
BPOST
Bpost SA NV
LATK
YIELDUSDT
Yield Protocol
USOTC
CHRCF
Chrysos (PK)
LSE
83YE
Barclays 23
EU
6323T
6323T
LSE
50DX
Barclays 26
GDAX
XRPUSDT
Ripple
LSE
FD14
Hsbc Bk.24
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados